Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome

SIMPLE SUMMARY: Immunosurveillance of cancer is mediated by T cell-based recognition of tumor-associated antigens, i.e., short peptides that are presented on the surface of cells on human leukocyte antigen (HLA) molecules. This encourages the analysis of the entirety of HLA-presented peptides, the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Marconato, Maddalena, Maringer, Yacine, Walz, Juliane S., Nelde, Annika, Heitmann, Jonas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563800/
https://www.ncbi.nlm.nih.gov/pubmed/36230581
http://dx.doi.org/10.3390/cancers14194659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563800/
https://www.ncbi.nlm.nih.gov/pubmed/36230581
http://dx.doi.org/10.3390/cancers14194659

Ejemplares similares